<VariationArchive VariationID="102445" VariationName="NM_001556.3(IKBKB):c.1292dup (p.Gln432fs)" VariationType="Duplication" Accession="VCV000102445" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-19" DateCreated="2018-12-01" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="108187" VariationID="102445">
      <GeneList>
        <Gene Symbol="IKBKB" FullName="inhibitor of nuclear factor kappa B kinase subunit beta" GeneID="3551" HGNC_ID="HGNC:5960" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="42271302" stop="42332460" display_start="42271302" display_stop="42332460" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="42128819" stop="42190170" display_start="42128819" display_stop="42190170" Strand="+" />
          </Location>
          <OMIM>603258</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001556.3(IKBKB):c.1292dup (p.Gln432fs)</Name>
      <CanonicalSPDI>NC_000008.11:42318599:GGGG:GGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8p11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="42318599" stop="42318600" display_start="42318599" display_stop="42318600" variantLength="1" positionVCF="42318599" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="42176117" stop="42176118" display_start="42176117" display_stop="42176118" variantLength="1" positionVCF="42176117" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>Q432fs</ProteinChange>
      <ProteinChange>Q373fs</ProteinChange>
      <ProteinChange>Q368fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.42176121dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.42176121dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.42318603dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.42318603dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_041793.1" sequenceAccession="NG_041793" sequenceVersion="1" change="g.52302dup">
            <Expression>NG_041793.1:g.52302dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190720.3" sequenceAccession="NM_001190720" sequenceVersion="3" change="c.1100dup">
            <Expression>NM_001190720.3:c.1100dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001177649.2" sequenceAccession="NP_001177649" sequenceVersion="2" change="p.Gln368fs">
            <Expression>NP_001177649.2:p.Gln368fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242778.2" sequenceAccession="NM_001242778" sequenceVersion="2" change="c.1115dup">
            <Expression>NM_001242778.2:c.1115dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001229707.1" sequenceAccession="NP_001229707" sequenceVersion="1" change="p.Gln373fs">
            <Expression>NP_001229707.1:p.Gln373fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001556.3" sequenceAccession="NM_001556" sequenceVersion="3" change="c.1292dup" MANESelect="true">
            <Expression>NM_001556.3:c.1292dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001547.1" sequenceAccession="NP_001547" sequenceVersion="1" change="p.Gln432fs">
            <Expression>NP_001547.1:p.Gln432fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033818.2" sequenceAccession="NR_033818" sequenceVersion="2" change="n.1534dup">
            <Expression>NR_033818.2:n.1534dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_033819.2" sequenceAccession="NR_033819" sequenceVersion="2" change="n.1478dup">
            <Expression>NR_033819.2:n.1478dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1241" sequenceAccession="LRG_1241">
            <Expression>LRG_1241:g.52302dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040009.2" sequenceAccession="NR_040009" sequenceVersion="2" change="n.1425dup">
            <Expression>NR_040009.2:n.1425dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1241t1" sequenceAccession="LRG_1241t1">
            <Expression>LRG_1241t1:c.1292dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1241p1" sequenceAccession="LRG_1241p1" change="p.Gln432fs">
            <Expression>LRG_1241p1:p.Gln432fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001556.2" sequenceAccession="NM_001556" sequenceVersion="2" change="c.1292dupG">
            <Expression>NM_001556.2:c.1292dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10602384" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603258.0001" DB="OMIM" />
        <XRef Type="rs" ID="886041036" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001556.3(IKBKB):c.1292dup (p.Gln432fs) AND Severe combined immunodeficiency due to IKK2 deficiency" Accession="RCV000088681" Version="3">
        <ClassifiedConditionList TraitSetID="12734">
          <ClassifiedCondition DB="MedGen" ID="C4747743">Severe combined immunodeficiency due to IKK2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2013-12-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001556.3(IKBKB):c.1292dup (p.Gln432fs) AND IKBKB-related disorder" Accession="RCV003945040" Version="1">
        <ClassifiedConditionList TraitSetID="89560">
          <ClassifiedCondition>IKBKB-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-12-01" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10195897</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24369075</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="89560" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70547" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">IKBKB-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">IKBKB-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="12734" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="18501" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 15</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY 15B</ElementValue>
                <XRef Type="MIM" ID="615592" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603258.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603258.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe combined immunodeficiency due to IKK2 deficiency</ElementValue>
                <XRef ID="MONDO:0014267" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IMD15B</ElementValue>
                <XRef Type="MIM" ID="615592" DB="OMIM" />
              </Symbol>
              <XRef ID="397787" DB="Orphanet" />
              <XRef ID="C4747743" DB="MedGen" />
              <XRef ID="MONDO:0014267" DB="MONDO" />
              <XRef Type="MIM" ID="615592" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="213857" SubmissionDate="2018-11-28" DateLastUpdated="2018-12-01" DateCreated="2014-03-20">
        <ClinVarSubmissionID localKey="603258.0001_IMMUNODEFICIENCY 15B" title="IKBKB, 1-BP DUP, 1292G_IMMUNODEFICIENCY 15B" />
        <ClinVarAccession Accession="SCV000121603" DateUpdated="2018-12-01" DateCreated="2014-03-20" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-12-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 patients of Cree ancestry from Canada with a primary immunodeficiency (IMD15B; 615592), Pannicke et al. (2013) identified a homozygous 1-bp duplication (c.1292dupG) in exon 13 of the IKBKB gene, resulting in a frameshift and premature termination (Gln432ProfsTer62) and the loss of most of the alpha-helical scaffold dimerization domain. The mutation was found by homozygosity mapping followed by sequencing of genes in the candidate region. The mutation was not found in the dbSNP or 1000 Genomes Project databases, and segregated with the disorder in the families. IKBKB mRNA was decreased in patient cells, likely reflecting nonsense-mediated mRNA decay. Western blot analysis of patient cells showed complete lack of the IKBKB protein, consistent with a loss of function. Patient cells also showed decreased protein levels of IKK1 (600664), IKBKG (300248), and p65 (NFKB3; 164014) compared to control cells. Functional and gene expression studies of patient fibroblasts showed variable effects on receptor activation and NFKB signaling involved in immunity. There was impaired phosphorylation of NFKBIA (164008) in response to stimulation with TNF-alpha (191160) and flagellin, which acts through TLR5 (603031), but only a marginally impaired response to IL1B (147720). IL6 (147620) response to TNFA was normal, but it was reduced in response to lipopolysaccharide, with acts through TLR4 (603030). These studies showed selective dependence of the regulation of NFKB target genes on IKBKB function. Patient peripheral blood B and T cells were almost exclusively of the naive type, and B, T, and NK cells showed poor differentiation or mitogenic responses under certain conditions. These findings were consistent with the role of IKBKB in transmitting signals by various surface receptors. Pannicke et al. (2013) noted that the phenotype in these patients with null mutations in IKBKB is not as severe as that in the null mouse model, which is lethal (Li et al., 1999).</Attribute>
              <Citation>
                <ID Source="PubMed">24369075</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10195897</ID>
              </Citation>
              <XRef DB="OMIM" ID="615592" Type="MIM" />
              <XRef DB="OMIM" ID="600664" Type="MIM" />
              <XRef DB="OMIM" ID="300248" Type="MIM" />
              <XRef DB="OMIM" ID="164014" Type="MIM" />
              <XRef DB="OMIM" ID="164008" Type="MIM" />
              <XRef DB="OMIM" ID="191160" Type="MIM" />
              <XRef DB="OMIM" ID="603031" Type="MIM" />
              <XRef DB="OMIM" ID="147720" Type="MIM" />
              <XRef DB="OMIM" ID="147620" Type="MIM" />
              <XRef DB="OMIM" ID="603030" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKB" />
          </GeneList>
          <Name>IKBKB, 1-BP DUP, 1292G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 1292G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603258.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">IMMUNODEFICIENCY 15B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8845854" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="3477048|IKBKB-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004758481" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The IKBKB c.1292dupG variant is predicted to result in a frameshift and premature protein termination (p.Gln432Profs*62). This variant has been reported in the homozygous state in several individuals with IKBKB-related immune deficiency (Pannicke et al. 2013. PubMed ID: 24369075; Rubin et al. 2018. PubMed ID: 30288645; Cuvelier et al. 2019. PubMed ID: 30391351). This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in IKBKB are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001556.2:c.1292dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">IKBKB-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="213857" TraitType="Disease" MappingType="Name" MappingValue="IMMUNODEFICIENCY 15B" MappingRef="Preferred">
        <MedGen CUI="C4747743" Name="Severe combined immunodeficiency due to IKK2 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8845854" TraitType="Disease" MappingType="Name" MappingValue="IKBKB-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="IKBKB-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

